Shares of Inovio Pharmaceuticals Inc. INO, -9.79% 7.5% was recovered in premarket operations on Friday, to extend its recent rocket launch to a maximum of 20 years, even as the biotech company was downgraded in Stifel Nicolaus over valuation concerns. The stock is up 119% amid a four-day streak to …
Read More »Inovio shares rise to extend rally to 20-year high, while Stifel says price is now ‘less palatable’
